LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

Home・Aandelen Lijst・Codexis Inc

Codexis Inc

Gesloten

SectorGezondheidszorg

1.66 4.4

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.53

Max

1.7

Belangrijke statistieken
By Trading Economics
Inkomsten	29M 9.6M
Verkoop	30M 39M
Winstmarge	24.672
Werknemers	146
EBITDA	33M 17M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+303.73% upside

Dividenden
By Dow Jones
Volgende Winsten	13 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	33M 146M
Vorige openingsprijs	-2.74
Vorige sluitingsprijs	1.66

Nieuwssentiment

By Acuity

60%

40%

303 / 350 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

2.25 / 2.53 Steun & Weerstand

Codexis Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 nov 2025, 21:37 UTC

Winsten

Codexis to Cut About 24% of Workforce

Peer Vergelijking

Prijswijziging

Codexis Inc Prognose

Koersdoel

By TipRanks

303.73% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6.5 USD 303.73%

Hoogste 11 USD

Laagste 2 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Codexis Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Codexis Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

2.25 / 2.53Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

303 / 350 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.